You are a moron but you keep posting the same #$%$. For the last time, I have no clue who is gator or Lizzard or anyone else for that matter.
You are definitely a pumper of the worst kind.
I am short HALO and will remain short HALO because the pipeline still has unresolved questions with FDA which will not be resolved until EOY. Current market conditions are favorable to biotechs and this thing cannot get any traction. HyQ is not approved in EU or US. Roche delaying until HALO runs out of money. 680+M in market cap for partnerships of less than 5% on revenues which will compete with the IV products of the same manufacturers. Good luck to your pumping this is going down and there is no doubt in my mind. Current market cap prices all partner drugs approved and sales fetching approx. 300M in revenue to HALO - very rosy and you think this is going higher?
I think My replies on Fezz ("EMA 67....") might move your timeline forward a bit. You kinda have to read them through to get the just of things. Anyway, EOY seems overly pessimistic, and other than a few no brainers of forthcoming good news, things will be fairly spread out through the year. But these are the things that will make people glad they bought in the fives. Besides arn't most shorters short term anyway??? You could change horses in a sec, right?